At this year's North American Cystic Fibrosis Conference in Anaheim, Calif., many of the CF Foundation's most generous and committed donors gathered to celebrate the milestones achieved over the past year in the fight against CF.
Site Search
The Cystic Fibrosis Foundation has increased its award to Arcturus Therapeutics to up to $15 million to develop a mutation-agnostic therapy for people with cystic fibrosis.
The Cystic Fibrosis Foundation awarded nearly $700,000 to Calibr, the drug discovery and development arm of Scripps Research, to screen for a compound that could be used to treat Burkholderia cepacia complex infections.
Recipients include four programs from around the country that engage and empower the CF community.
The CF Foundation has successfully completed a sale of its remaining stake in royalties related to Vertex's CFTR modulators for an upfront payment of $575 million and a potential future payment of $75 million, bringing additional resources to the fight against CF.
Poner atención a la diversidad de voces es fundamental a medida que continuamos con nuestra meta de escuchar, aprender y actuar contra el racismo y la discriminación.
Thirty-three new projects are being funded as part of the Foundation's $100 million Infection Research Initiative.